Chimerix (CMRX) Reports In-Line Q1 EPS, Announces Strategy Update
FREE Breaking News Alerts from StreetInsider.com!
StreetInsider.com Top Tickers, 8/14/2026
- Wall St set for muted open as Middle East tensions curb risk appetite
- BofA's Hartnett explains why Wall Street is trading with 'no fear'
- Oil rises after US threatens indefinite blockade of Iran; set for weekly gains
- Are KOSPI and SOX in a bubble? Citi answers
- Could Intel return to the red-hot memory market after $20B raise and recent hire?
Chimerix Announces First Quarter 2019 Financial Results and Strategy Update
May 9, 2019 8:00 AM EDTReports Positive Top-line Survival Data from Pivotal Mouse Study as Key Milestone on Path to Smallpox Regulatory Submission
Plan to Focus on Execution of Smallpox Program, Halting All Other Brincidofovir Development Activities
Restructuring to Reduce Workforce by More Than 50%, Maintaining Key Capabilities and Preserving Capital for New Programs
Conference Call at 8:30 a.m. ET Today
DURHAM, N.C., May 09, 2019 (GLOBE NEWSWIRE) -- Chimerix (NASDAQ: CMRX), today reported financial results for the first quarter ended March 31, 2019 and provided an update on... More
